Inidascamine
AssetAlso RL-007
- Stage
- Human trials
- Modality
- Small molecule
- Target
- Not known
- 1
- Indication
- 0
- Trials
- 1
- Developer
Indications
1Cognitive impairment associated with schizophrenia
Human trials, prnewswire.com, 7 Oct 2026
In the full profile
- Owner and partners2
- Signals1
Every asset’s record: target, stage, trials and the evidence behind it.